These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2525295)

  • 1. [Loratadine. A new, non-sedating antihistaminc agent].
    Frølund L; Bindslev-Jensen C; Dirksen A
    Ugeskr Laeger; 1989 May; 151(22):1410-2. PubMed ID: 2525295
    [No Abstract]   [Full Text] [Related]  

  • 2. Loratadine, a non-sedating H1-receptor antagonist (antihistamine).
    Simons FE
    Ann Allergy; 1989 Oct; 63(4):266-8. PubMed ID: 2572187
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis.
    Dockhorn RJ; Bergner A; Connell JT; Falliers CJ; Grabiec SV; Weiler JM; Shellenberger MK
    Ann Allergy; 1987 Jun; 58(6):407-11. PubMed ID: 2954497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Loratadine inhibits mediator liberation from a suspension of human pulmonary mast cells].
    Peters SP
    Allerg Immunol (Paris); 1991 Mar; 23(3):109. PubMed ID: 1712595
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disodium cromoglycate in comparison with antihistaminics (loratadine) in seasonal allergic rhinitis].
    Schultze-Wernighaus G
    Z Hautkr; 1988; 63 Suppl 4():31-4. PubMed ID: 2978099
    [No Abstract]   [Full Text] [Related]  

  • 6. N-substituted 11-(4-piperidylene)-5,6-dihydro-11H-benzo-[5,6]cyclohepta [1,2-b]pyridines. Antihistamines with no sedating liability.
    Villani FJ; Magatti CV; Vashi DB; Wong J; Popper TL
    Arzneimittelforschung; 1986 Sep; 36(9):1311-4. PubMed ID: 2947582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of the nonsedating antihistamine loratadine plus pseudoephedrine in the symptomatic management of the common cold.
    Berkowitz RB; Connell JT; Dietz AJ; Greenstein SM; Tinkelman DG
    Ann Allergy; 1989 Oct; 63(4):336-9. PubMed ID: 2529799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiallergic activity of loratadine, a non-sedating antihistamine.
    Kreutner W; Chapman RW; Gulbenkian A; Siegel MI
    Allergy; 1987 Jan; 42(1):57-63. PubMed ID: 2436504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hay fever with loratadine--a new non-sedating antihistamine.
    Irander K; Odkvist LM; Ohlander B
    Allergy; 1990 Feb; 45(2):86-91. PubMed ID: 2138436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action.
    Oei HD
    Ann Allergy; 1988 Dec; 61(6):436-9. PubMed ID: 2904776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihistaminic effects of rupatadine and PKPD modelling.
    Peña J; Carbo ML; Solans A; Nadal T; Izquierdo I; Merlos M
    Eur J Drug Metab Pharmacokinet; 2008; 33(2):107-16. PubMed ID: 18777946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
    Abu Shareeah AM
    Int J Dermatol; 1992 May; 31(5):355-6. PubMed ID: 1534077
    [No Abstract]   [Full Text] [Related]  

  • 13. Computed phonetograms in adult patients with benign voice disorders before and after treatment with a nonsedating antihistamine (loratadine).
    Pedersen MF
    Folia Phoniatr (Basel); 1991; 43(2):60-7. PubMed ID: 1833295
    [No Abstract]   [Full Text] [Related]  

  • 14. Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis.
    Grossman J; Bronsky EA; Lanier BQ; Linzmayer MI; Moss BA; Schenkel EJ; Selner JC
    Ann Allergy; 1989 Oct; 63(4):317-21. PubMed ID: 2529798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and dose proportionality of loratadine.
    Hilbert J; Radwanski E; Weglein R; Luc V; Perentesis G; Symchowicz S; Zampaglione N
    J Clin Pharmacol; 1987 Sep; 27(9):694-8. PubMed ID: 2960701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of pruritic skin diseases with loratadine. Results of an open multicenter study].
    Paul E
    Fortschr Med; 1991 Mar; 109(7):175-8. PubMed ID: 1827771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretion of loratadine in human breast milk.
    Hilbert J; Radwanski E; Affrime MB; Perentesis G; Symchowicz S; Zampaglione N
    J Clin Pharmacol; 1988 Mar; 28(3):234-9. PubMed ID: 2966185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rupatadine: pharmacological profile and its use in the treatment of allergic disorders.
    Picado C
    Expert Opin Pharmacother; 2006 Oct; 7(14):1989-2001. PubMed ID: 17020424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loratadine: multiple-dose pharmacokinetics.
    Radwanski E; Hilbert J; Symchowicz S; Zampaglione N
    J Clin Pharmacol; 1987 Jul; 27(7):530-3. PubMed ID: 2958516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rupatadine, oral Rupatall].
    J Pharm Belg; 2010 Mar; (1):24. PubMed ID: 20429393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.